The year-end dividend for the fiscal year ending December 2025 is 60 yen per share, with a total dividend amount of 4,460 million yen. A transfer of 8,300 million yen from special reserves to retained earnings will be made, effective March 9, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4967","jir_company_name":"Kobayashi Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-18","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4967-20260218-02.pdf","jir_short_summary":"The year-end dividend for the fiscal year ending December 2025 is 60 yen per share, with a total dividend amount of 4,460 million yen. A transfer of 8,300 million yen from special reserves to retained earnings will be made, effective March 9, 2026.","jir_summary":"### Overview of Dividend\nKobayashi Pharmaceutical Co., Ltd. has decided on a year-end dividend of 60 yen per share for the fiscal year ending December 31, 2025, resulting in a total dividend amount of 4,460 million yen. This represents an increase from 59 yen per share and 4,385 million yen in the previous fiscal year. The annual dividend amounts to 104 yen when combined with the interim dividend of 44 yen, reflecting the company\u2019s basic policy of maintaining stable dividend payments. The dividend source is retained earnings, and the effective date is March 9, 2026.\n\n### Regarding the Withdrawal of Special Reserves\nOn the same date, a transfer of 8,300,000,000 yen from special reserves to retained earnings will be conducted. This action aims to facilitate flexible and stable dividend payments and is an account transfer within the net assets section of the balance sheet, thus having no impact on net assets or financial performance. The effective date coincides with that of the dividend, March 9, 2026.","jir_financial_highlights":"Year-End Dividend per Share: 60.00 yen (Increased from 59.00 yen in the previous fiscal year)\nTotal Dividend Amount: 4,460 million yen (Increased from 4,385 million yen in the previous fiscal year)\nWithdrawal Amount of Special Reserves: 8,300,000,000 yen (Unknown)","jir_category":"","jir_hashtags":"#KobayashiPharmaceutical, #DividendRelated, #JapaneseStocks","jir_key_figures":"Year-End Dividend: 60.00 yen (Fiscal Year Ending December 2025)\nTotal Dividend Amount: 4,460 million yen (Fiscal Year Ending December 2025)\nWithdrawal Amount of Special Reserves: 8,300,000,000 yen","jir_meta_title":"Kobayashi Pharmaceutical Announces Year-End Dividend of 60 Yen for 2025 and 4,460 Million Yen Total Dividend with Withdrawal of 8,300 Million Yen from Special Reserves","jir_meta_description":"Kobayashi Pharmaceutical Co., Ltd. has decided on a year-end dividend of 60 yen per share for the fiscal year ending 2025, totaling 4,460 million yen. Additionally, 8,300 million yen from special reserves will be transferred to retained earnings to ensure continued stable dividends.","jir_og_title":"Kobayashi Pharmaceutical Announces Year-End Dividend of 60 Yen for 2025","jir_og_description":"Kobayashi Pharmaceutical has set the year-end dividend for fiscal 2025 at 60 yen per share and will transfer 8,300 million yen from special reserves to retained earnings.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7982,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-29990","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n